Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Veronika Režnáková"'
Autor:
Vladimira Durmanova, Juraj Javor, Zuzana Parnicka, Gabriel Minarik, Agata Ocenasova, Barbora Vaseckova, Veronika Reznakova, Maria Kralova, Tomas Hromadka, Ivana Shawkatova
Publikováno v:
Mediators of Inflammation, Vol 2021 (2021)
Alzheimer’s disease (AD) is a chronic neurodegenerative disease of the central nervous system with higher prevalence in elderly people. Despite numerous research studies, the etiopathogenesis of AD remains unclear. Matrix metalloproteinases (MMPs)
Externí odkaz:
https://doaj.org/article/205393bd007749a3bcaa62ae13a91a5c
Autor:
Juraj Javor, Vladimíra Ďurmanová, Kristína Klučková, Zuzana Párnická, Dominika Radošinská, Stanislav Šutovský, Barbora Vašečková, Veronika Režnáková, Mária Králová, Karin Gmitterová, Štefan Zorad, Ivana Shawkatová
Publikováno v:
Life, Vol 14, Iss 3, p 346 (2024)
Adiponectin, a hormone secreted by adipose tissue, plays a complex role in regulating metabolic homeostasis and has also garnered attention for its potential involvement in the pathogenesis of late-onset Alzheimer’s disease (LOAD). The objective of
Externí odkaz:
https://doaj.org/article/7a00708bb4324c24baeb223900fa213d
Autor:
Juraj Javor, Barbora Vašečková, Veronika Režnáková, Maria Kralova, Ivana Shawkatová, Ján Pečeňák, Peter Filipcik, Gabriel Minarik, Vladimíra Ďurmanová, Zuzana Párnická
Publikováno v:
Biologia. 74:1531-1538
Intercellular Adhesion Molecule-1 (ICAM-1) is a cell surface glycoprotein with possible involvement in the pathogenesis of Alzheimer’s disease (AD). Therefore, sequence variations in the ICAM1 gene affecting ICAM-1 structure or expression level may
Autor:
Tomas Hromadka, Veronika Režnáková, Gabriel Minarik, Maria Kralova, Ľubica Peterajová, Barbora Vašečková, Stanislav Šutovský, Ján Pečeňák, Vladimíra Ďurmanová, Juraj Javor, Ivana Shawkatová, Zuzana Párnická, Karin Gmitterová
Publikováno v:
International journal of immunogeneticsREFERENCES. 47(5)
CD33 rs3865444:C>A single nucleotide polymorphism (SNP) has been previously associated with the risk of late-onset Alzheimer's disease (LOAD); however, the results have been inconsistent across different populations. CD33 is a transmembrane receptor